Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hull Hans
Chief Business Officer at PLIANT THERAPEUTICS. Filing since 20 Dec 2022.
CIK 0001614876
Company
Date
Role
Action
Shares
Amount
Of holding
PLRX
PLIANT THERAPEUTICS, INC.
17 Jan 2025
Chief Business Officer
Sold on a plan
15,936
$178.50K
7.0%
PLRX
PLIANT THERAPEUTICS, INC.
10 Jul 2024
Chief Business Officer
Sold on a plan
9,900
$114.44K
4.2%
PLRX
PLIANT THERAPEUTICS, INC.
17 Jan 2024
Chief Business Officer
Sold on a plan
9,786
$168.61K
5.0%
PLRX
PLIANT THERAPEUTICS, INC.
4 Aug 2023
Chief Business Officer
Sold on a plan
20,050
$401.20K
9.3%
PLRX
PLIANT THERAPEUTICS, INC.
3 Aug 2023
Chief Business Officer
Sold on a plan
13,069
$261.38K
6.0%
PLRX
PLIANT THERAPEUTICS, INC.
3 Aug 2023
Chief Business Officer
Bought on a plan
1,800
$36.00K
0.9%
PLRX
PLIANT THERAPEUTICS, INC.
17 Jul 2023
Chief Business Officer
Sold on a plan
17,937
$323.03K
7.6%
PLRX
PLIANT THERAPEUTICS, INC.
30 Mar 2023
Chief Business Officer
Sold on a plan
9,036
$239.64K
4.3%
PLRX
PLIANT THERAPEUTICS, INC.
20 Dec 2022
Chief Business Officer
Sold, plan not stated
8,748
$167.11K
6.0%
9 decisions on file.
